Related Experiment Video
Updated: Oct 24, 2025
10:20
Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
40.0K
Disrupting RhoA activity by blocking Arhgef3 expression mitigates microglia-induced neuroinflammation post spinal
Liang Liao1, Zhan-Yang Qian2, Xin-Yu Li3
1Department of Orthopedics, Bengbu Third People's Hospital, 233000 Bengbu, China.
Journal of Neuroimmunology
|August 14, 2021
Summary
Inhibiting Arhgef3 reduces inflammatory microglia activation and secondary injury following spinal cord injury (SCI). This approach improves locomotor recovery in mice, suggesting Arhgef3 as a therapeutic target for SCI.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia activation exacerbates spinal cord injury (SCI) pathology.
- Arhgef3 expression correlates with microglia activation and inflammatory responses.
Purpose of the Study:
- To investigate the role of Arhgef3 in microglia activation and inflammation post-SCI.
- To evaluate the therapeutic potential of inhibiting Arhgef3 in a murine SCI model.
Main Methods:
- In vitro studies using lipopolysaccharide (LPS)-stimulated microglia.
- In vivo experiments using a mechanical contusion-induced SCI mouse model.
- Analysis of Arhgef3 expression, RhoA activation, inflammatory cytokines, ROS generation, and locomotor recovery.
Main Results:
- LPS upregulated Arhgef3, which activated RhoA and promoted microglia inflammation.
- Arhgef3 inhibition decreased RhoA activation, suppressed pro-inflammatory cytokines and ROS generation, and alleviated inflammatory gene expression.
- In vivo, Arhgef3 inhibition mitigated microglial inflammation, reduced secondary neurological injury, and improved locomotor recovery, without affecting neuronal regeneration.
Conclusions:
- Arhgef3 plays a critical role in microglia activation and inflammatory response after neural injury.
- Targeting Arhgef3 represents a promising therapeutic strategy for preventing and treating spinal cord injury.
